Active

RNA Pioneering

Switched

BE0456792695

Rechtspersoon Public limited company 1 establishment

Rijvisschestraat 120, 9052 Gent Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

30 year, 8 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -111,461

▼ 37% vs 2024

Profit

Caution

€ -128,247

▼ 2% vs 2024

Debts

Low

€ 117,829

▲ 229% vs 2024

RNA Pioneering from Gent, company number BE0456792695, closed financial year 2025 with a result of € -128,247 after tax. For that financial year RNA Pioneering recorded a gross margin of € -111,461 and equity of € 5.5 million. Compared with financial year 2024, the result moved from € -125,999 to € -128,247. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What happened at RNA Pioneering?

What happened at RNA Pioneering in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Bellevue NV stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 128,247. Source: NBB ↗
  • Bellevue NV became a director. NBB
  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO

In short

From € 205,754 profit in 2021 to € 128,247 loss in 2025.

Paid € 1,300 in corporate taxes since 2021.

Best year ever: 2021, with € 205,754 profit.

A new publication or filing at RNA Pioneering? We notify you, reason included.

Follow RNA Pioneering

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

RNA Pioneering
Ziphius 59%

It owns 59% of Ziphius itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bellevue NV

Director · represented by Christiaan Cardon

Also active at: BORDEAUX I

since 2022 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Rijvisschestraat 120

9052 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0456.792.695
VAT number
BE 0456.792.695
Registered office
Rijvisschestraat 120, 9052 Gent
Names & denominations
RNA Pioneering
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
29 December 1995
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Vervaardiging van geneesmiddelen

Frequently asked questions

What is the enterprise number of RNA Pioneering?
The enterprise number of RNA Pioneering is BE0456792695.
What is the address of RNA Pioneering?
The registered office of RNA Pioneering is located at Rijvisschestraat 120, 9052 Gent.
When was RNA Pioneering founded?
RNA Pioneering was founded on 29 December 1995.
What is the main activity of RNA Pioneering?
The main activity of RNA Pioneering is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does RNA Pioneering have a website?
No website is currently known for RNA Pioneering.
How much profit did RNA Pioneering make in 2025?
RNA Pioneering recorded a loss after taxes of € 128,247 in financial year 2025.
What is the revenue of RNA Pioneering?
As a small company, RNA Pioneering is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -111,461.
Where can I find the annual accounts of RNA Pioneering?
RNA Pioneering files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of RNA Pioneering?
According to the 2025 annual accounts, the directors of RNA Pioneering are: Bellevue NV.
Who owns RNA Pioneering?
It owns 59% of Ziphius itself.